Inflammatory Bowel Disease in Cats: Welfare Management and Diet

Feline inflammatory bowel disease causes chronic gastrointestinal upset with significant welfare impacts that can be substantially improved through dietary and medical management.

Key Facts

Feline IBD encompasses lymphocytic-plasmacytic, eosinophilic, and neutrophilic forms
Clinical signs include chronic vomiting, diarrhoea, weight loss, and reduced appetite
Distinguishing IBD from alimentary lymphoma requires intestinal biopsy for definitive diagnosis
Dietary management with novel protein or hydrolysed diets is first-line treatment in many cases
Immunosuppressive treatment with prednisolone is effective for moderate to severe IBD

Welfare Considerations

Cats with IBD experience chronic welfare impacts from nausea, abdominal discomfort, vomiting, and progressive weight loss. The condition affects appetite and eating comfort, disrupting one of cats' core welfare indicators. Untreated IBD can progress to alimentary lymphoma. Appropriate dietary management and immunosuppressive therapy can induce remission, substantially improving quality of life. Regular monitoring enables early detection of relapse and medication adjustment.

What You Can Do

Seek veterinary assessment for cats with chronic vomiting or weight loss
Trial a novel protein diet for 6-8 weeks under veterinary supervision
Maintain consistent feeding of the therapeutic diet once a beneficial diet is identified
Monitor body weight regularly as a welfare indicator of disease control
Work with your vet to develop a long-term IBD management and monitoring plan